Table 2.
Percentage of CD4+FOXP3+ cells in CD4+CD127+/−CD25+/− subsets in BM mononuclear cells (BMMCs) and peripheral blood mononuclear cells (PBMCs) isolated from OA and RA patients (n = 6 in each group); ns—not significant.
| OA BMMCs | OA PBMCs | ||||||
| Mean % of the Cells | Range | Median | Mean % of the Cells | Range | Median | p -Value | |
| CD127+CD25+ | 4.8 | 0.0–14.3 | 1.8 | 21.0 | 5.0–36.4 | 21.9 | 0.02 |
| CD127+CD25− | 1.8 | 0.2–5.6 | 1.3 | 1.1 | 0.2–1.9 | 1.1 | ns |
| CD127–CD25+ | 41.0 | 14.3–62.5 | 47.1 | 59.4 | 43.7–75.0 | 57.6 | ns |
| CD127–CD25− | 11.9 | 5.2–38.5 | 6.8 | 8.9 | 5.1–13.3 | 8.5 | ns |
| RA BMMCs | RA PBMCs | ||||||
| Mean % of the Cells | Range | Median | Mean % of the Cells | Range | Median | p -Value | |
| CD127+CD25+ | 7.7 | 0.0–20.0 | 3.9 | 13.6 | 2.2–33.3 | 8.3 | ns |
| CD127+CD25− | 1.6 | 0.9–2.5 | 1.4 | 0.9 | 0.2–2.1 | 0.8 | ns |
| CD127−CD25+ | 9.3 | 0.0–28.6 | 3.6 | 41.7 | 13.5–77.7 | 40.2 | 0.016 |
| CD127−CD25− | 4.5 | 1.7–11.8 | 2.5 | 8.4 | 2.6–22.5 | 4.3 | ns |